Generate Biomedicines
NASDAQ: GENBSomerville, US · Incorporated in Delaware · 4 known investors
Generate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.
Founders & leadership
GG
Gevorg GrigoryanCo-Founder & Chief Technology Officer